George Tidmarsh has only been at the Center for Drug Evaluation and Research for nine days, but will now add supervision of a second FDA division to his portfolio after Vinay Prasad’s sudden departure.
New CDER Head Tidmarsh Will Sub In At Biologics Group After Prasad’s Exit Read More »
In light of the results, executives backed away from prior behavioral health growth targets for 2025, though they slightly raised the midpoint of overall revenue guidance.
UHS posts softer-than-expected volumes for second consecutive quarter Read More »
As analysts parsed news of Vinay Prasad’s ouster, worries over drug approval delays, cell and gene therapy impacts and more were top of mind.
Exit Stage Right: With Prasad Out, Analysts Hope for More Traditional Replacement Read More »
The average monthly bid submitted by insurers for 2026 prescription drug plans increased 33% from last year, according to data released by the CMS.
Medicare Part D premiums likely to increase next year Read More »
Los métodos actuales para detectar anticuerpos, como los ensayos serológicos convencionales, tienen limitaciones en cuanto a la cantidad de información que pueden procesar en una sola prueba. Aunque técnicas más recientes han permitido ampliar el número de m …
Nueva técnica para el análisis serológico masivo Read More »
This earnings season, top medical device companies have dramatically reduced their expectations for tariff impacts in 2025. Check out MedTech Dive’s coverage.
Steve Collis’ three decades of experience at a major drug distributor could prove helpful for Elevance as it continues to build out its pharmacy services.
En un estudio reciente, se ha descubierto que la metástasis hepática desaparece casi por completo cuando se elimina cierto tipo de célula activada por el cáncer. Los ensayos realizados en ratones muestran que las células estrelladas del hígado, que por s&iac …
El inesperado papel de un tipo de célula en la metástasis hepática Read More »
U.S. District Judge Brian Miller agreed with pharmacy benefit managers that the state’s law may violate the Constitution in granting their request for a preliminary injunction.
Judge halts Arkansas law forcing PBMs to sell pharmacies Read More »
Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for clinical trials in early 2026.
Madrigal Makes Potential $2B+ Bet for CSPC’s GLP-1 Pill Read More »
